Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 515

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Chemotherapy‐driven dysbiosis in the intestinal microbiome

Open access
Montassier, E., Gastinne, T., Vangay, P., Al‐Ghalith, G. A., Bruley des Varannes, S., Massart, S., Moreau, P., Potel, G., de La Cochetière, M. F., Batard, E., Knights, D.·2015·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Chemotherapy is commonly used as myeloablative conditioning treatment to prepare patients for haematopoietic stem cell transplantation (HSCT). Chemotherapy leads to several side effects, with gastrointestinal (GI) mucositis being one of the most frequent. Current models of GI mucositis pathophysiology are generally silent on the role of the intestinal microbiome. Aim: To identify functional mechanisms by which the intestinal microbiome may play a key role in the pathophysiology of GI mucositis, we applied high‐throughput DNA‐sequencing analysis to identify microbes and microbial functions that are modulated following chemotherapy. Methods: We amplified and sequenced 16S rRNA genes from faecal samples before and after chemotherapy in 28 patients with non‐Hodgkin's lymphoma who received the same myeloablative conditioning regimen and no other concomitant therapy such as antibiotics. Results: We found that faecal samples collected after chemotherapy exhibited significant decreases in abundances of Firmicutes (P = 0.0002) and Actinobacteria (P = 0.002) and significant increases in abundances of Proteobacteria (P = 0.0002) compared to samples collected before chemotherapy. Following chemotherapy, patients had reduced capacity for nucleotide metabolism (P = 0.0001), energy metabolism (P = 0.001), metabolism of cofactors and vitamins (P = 0.006), and increased capacity for glycan metabolism (P = 0.0002), signal transduction (P = 0.0002) and xenobiotics biodegradation (P = 0.002). Conclusions: Our study identifies a severe compositional and functional imbalance in the gut microbial community associated with chemotherapy‐induced GI mucositis. The functional pathways implicated in our analysis suggest potential directions for the development of intestinal microbiome‐targeted interventions in cancer patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13302

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 59

  1. 10.1200/JCO.1993.11.10.1846 · doi:10.1200/jco.1993.11.10.1846
  2. 10.1002/cncr.11671 · DOI · Paper page
  3. 10.1038/sj.bmt.1704563 · DOI
  4. 10.1136/gut.47.5.632 · DOI · Paper page
  5. 10.1038/nrc1318 · DOI · Paper page
  6. 10.1016/j.jinf.2014.05.018 · DOI
  7. 10.1111/apt.12878 · DOI · Paper page
  8. 10.1371/journal.ppat.1000879 · DOI · Paper page
  9. 10.1007/s00248-013-0355-4 · DOI · Paper page
  10. 10.1371/journal.pone.0002836 · DOI · Paper page
  11. 10.1111/j.1574-6976.2010.00251.x · DOI · Paper page
  12. 10.1016/j.chom.2013.08.006 · DOI · Paper page
  13. 10.1038/nmeth.2212 · DOI · Paper page
  14. 10.1073/pnas.1000087107 · DOI · Paper page
  15. 10.1038/ismej.2014.3 · DOI · Paper page
  16. 10.1186/gb-2012-13-9-r79 · DOI · Paper page
  17. 10.1038/ismej.2013.223 · DOI · Paper page
  18. 10.1016/j.chom.2014.02.005 · DOI · Paper page
  19. 10.1046/j.1365-2958.1997.4281787.x · DOI · Paper page
  20. 10.1016/j.tim.2004.09.002 · DOI · Paper page
  21. 10.1016/j.ijfoodmicro.2007.07.039 · DOI
  22. 10.1094/MPMI-18-0891 · DOI
  23. 10.1128/IAI.69.6.3523-3535.2001 · DOI · Paper page
  24. 10.1038/ismej.2014.64 · DOI · Paper page
  25. 10.3748/wjg.v20.i8.2051 · DOI
  26. 10.1016/j.cell.2014.09.022 · DOI · Paper page
  27. 10.1038/nature07540 · DOI · Paper page
  28. 10.1152/physrev.1990.70.2.567 · DOI · Paper page
  29. 10.1515/BC.2002.042 · DOI · Paper page
  30. Ashoori M, 2014, Riboflavin (vitamin B2) and oxidative stress: a review, Br J Nutr, 000, 1
  31. 10.1016/S1353-8020(02)00018-4 · DOI · Paper page
  32. 10.2174/1874312901206010259 · DOI
  33. 10.1155/2011/282356 · DOI
  34. 10.1111/j.1348-0421.2011.00398.x · DOI · Paper page
  35. 10.1136/gut.47.3.397 · DOI · Paper page
  36. 10.1038/sj.bjp.0706784 · DOI
  37. 10.1016/0006-2952(70)90026-2 · DOI
  38. Moallem SA, 2008, A study of acute and chronic anti‐nociceptive and anti‐inflammatory effects of thiamine in mice, Iran Biomed J, 12, 173
  39. Verhasselt V, 1950, Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14‐dependent pathway, J Immunol, 1997, 2919
  40. 10.1023/B:DDAS.0000011604.45531.2c · DOI
  41. 10.1186/1471-2407-13-56 · DOI
  42. 10.1007/BF02236743 · DOI
  43. 10.1097/SPC.0b013e328343a043 · DOI
  44. 10.1053/j.gastro.2005.12.015 · DOI · Paper page
  45. 10.1136/gut.2009.179325 · DOI
  46. 10.3748/wjg.v17.i12.1519 · DOI · Paper page
  47. 10.1038/mi.2014.107 · DOI · Paper page
  48. 10.1016/j.ajpath.2012.10.014 · DOI · Paper page
  49. 10.1183/09031936.05.00064704 · DOI
  50. 10.1007/s10753-008-9099-6 · DOI
  51. 10.1073/pnas.0803124105 · DOI · Paper page
  52. 10.1093/jn/136.6.1558 · DOI · Paper page
  53. 10.1046/j.1440-1746.2000.02037.x · doi:10.1046/j.1440-1746.2000.02037.x
  54. 10.1007/BF02208583 · doi:10.1007/bf02208583
  55. 10.1007/s10096-013-1819-7 · DOI · Paper page
  56. 10.1111/j.1399-3062.2005.00088.x · DOI · Paper page
  57. 10.1038/sj.bmt.1705690 · DOI · Paper page
  58. 10.1093/cid/cis765 · DOI
  59. 10.1111/tid.12175 · DOI

Cited by

See all 515

Metadata

Authors
Montassier, E., Gastinne, T., Vangay, P., Al‐Ghalith, G. A., Bruley des Varannes, S., Massart, S., Moreau, P., Potel, G., de La Cochetière, M. F., Batard, E., & Knights, D.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2015-07-06
Volume
42
Issue
5
Pages
515-528
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1716533099
Cited by
515
References
13
FWCI
8.75
Type
journal article
Language
en
Open access
bronze
Funders
Nantes University Hospital (BRD/10/04-Q)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.